http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1492897-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb75b0b19820e3833ebdcb31603b242b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-833 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-742 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-742 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
| filingDate | 1975-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1977-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1492897-A |
| titleOfInvention | Antibiotic 342-14-i and the production thereof |
| abstract | 1492897 Compositions containing antibiotic 342-14-I SHIONOGI & CO Ltd 10 June 1975 [19 June 1974] 24864/75 Heading A5B [Also in Division C3] A pharmaceutical composition comprises an antibiotic or an acid addition salt, metal salt or ammonium salt thereof, and a pharmaceutically acceptable diluent, carrier or excipient wherein said antibiotic, designated 342-14-I is a colourless amphoteric powder which melts with decomposition at 190- 195C, shows an elementary analysis of C 54.63%, H 7.12%, N 14.81%, O 23.44%, has a molecular weight of about 1450 and yields, upon acid hydrolysis, aspartic acid, threonine, glycine, valine, isoleucine, threonine, phenylalanine, tryptophan, 2, 4 - diaminobutyric acid, ammonia and anteisononanoic acid. The antibiotic is preferably obtained by cultivation of the microorganism Bacillus brevis. The composition may also comprise a stabiliser, an emulsifier, a preservative and/or a wetting agent, in the form of an injectable composition, a liquid, a suspension, a dispersion, an emulsion, an ointment, a tablet or a capsule. The compositions may be used to disinfect articles or building structures. For the inhibition of growth of grampositive pathogenic microorganisms in non- human animals it is preferred to use a dose of 0.1-100 mg of antibiotic per kg of body weieht via oral, subcutaneous or intravenous administration. |
| priorityDate | 1974-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.